FindTrial
Sign In

The application of next generation sequencing in the diagnosis, treatment and monitoring of therapeutic effect for pediatric leukemia/ lymphoma

Establishment and application of gene database of childhood leukemia and lymphoma in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025690
Enrollment
Unknown
Registered
2019-09-05
Start date
2015-01-01
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia/lymphoma

Interventions

Gold Standard:bone marrow examination/pathological biopsy
Index test:NGS

Sponsors

Children Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: The children were diagnosed as leukemia/lymphoma by bone marrow examination/pathological biopsy. The age at diagnosis was less than 18 years old. The family members of the children agreed to be included in this study.

Exclusion criteria

Exclusion criteria: Family members of children are reluctant to join the group

Design outcomes

Primary

MeasureTime frame
Bone maroow exam;survival;—

Countries

China

Contacts

Public ContactJianwen Xiao

Children Hospital of Chongqing Medical University

tomahawk6502@sohu.com+86 13527449631

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026